Daytrana: Clinical Trials

12 trials of Daytrana, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 active not recruiting, 1 recruiting, 1 terminated. 5 Phase 3, 5 Phase 4, 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Active not recruiting 2
Phase 45Completed 3, Recruiting 1, Terminated 1
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Active not recruiting 1

Follow Daytrana: new trials by email Literature Review of Daytrana trials Research Report on Daytrana

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
Exercise Intervention, Methylphenidate, Placebo - Prostate Carcinoma
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center2002019-03-252026-10-07
Stimulant Effects on Disruptive Behavior
Stimulant - Attention Deficit Hyperactivity Disorder, Problem Behavior
Phase 4RecruitingMatthew J O'Brien, PhD, BCBA-D102018-10-012025-03-17
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
Laboratory Biomarker Analysis, Methylphenidate, Physical Activity - Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm
Phase 3Active not recruitingM.D. Anderson Cancer Center2122018-08-022026-10-06
General Anesthesia Emergence Induced by Methylphenidate
Methylphenidate HCl, Placebo - Delayed Emergence From Anesthesia
Phase 1CompletedNicoleta Stoicea542014-05-012022-07-12
Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
Transdermal Methylphenidate - Dementia, Accidental Falls
Phase 4TerminatedSt. Louis University142012-11-012018-07-24
Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD
Daytrana - Attention Deficit Hyperactivity Disorder, INSOMNIA
Not applicableCompletedCox Health Systems262009-12-012012-07-19
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
Methylphenidate transdermal system, Lisdexamfetamine dimesylate, Osmotic-release oral system methylphenidate (OROS MPH) - Attention Deficit Disorder With Hyperactivity
Phase 4CompletedDuke University2282009-04-012013-09-30
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
Methylphenidate Transdermal System - ADHD
Phase 3CompletedNoven Therapeutics1632007-08-012017-04-26
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
methylphenidate transdermal system, Placebo - ADHD
Phase 3CompletedNoven Therapeutics2172007-07-012017-04-26
Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD
Methylphenidate Transdermal System (MTS), placebo patch - Attention Deficit Hyperactivity Disorder
Phase 3CompletedUniversity of Utah922007-06-012015-01-16
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
Daytrana - Attention Deficit Hyperactivity Disorder
Phase 4CompletedNoven Therapeutics3092007-01-012017-04-26
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
Methylphenidate Transdermal System, Placebo - ADHD, Attention Deficit Hyperactivity Disorder
Phase 4CompletedMassachusetts General Hospital362006-09-012012-11-16

Conditions studied

Attention Deficit Disorder with Hyperactivity (8)  ·  Alzheimer Disease (1)  ·  Delayed Emergence from Anesthesia (1)  ·  Dementia (1)  ·  Lethargy (1)  ·  Neoplasm Metastasis (1)  ·  Problem Behavior (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Sponsors

Noven Therapeutics (3)  ·  M.D. Anderson Cancer Center (2)  ·  Cox Health Systems (1)  ·  Duke University (1)  ·  Massachusetts General Hospital (1)  ·  Matthew J O'Brien, PhD, BCBA-D (1)  ·  Nicoleta Stoicea (1)  ·  St. Louis University (1)  ·  University of Utah (1)

Countries

United States (12)

Top investigators

Timothy Wilens, MD (2)  ·  Ahmed A Baig, M.D. (1)  ·  Frederick W. Reimherr, MD (1)  ·  George T Grossberg, M.D. (1)  ·  John S. March, MD, MPH (1)  ·  Matthew J O'Brien, PhD (1)  ·  Nicoleta Stoicea, MD, PhD (1)  ·  Robert L Finding, MD (1)  ·  Robert L. Findling, M.D. (1)  ·  Sriram Yennu (1)  ·  Sriram Yennu, MD (1)

Results publications

PMID 20492851, PMID 20625364, PMID 20973707, PMID 21494336, PMID 22100691, PMID 22115000, PMID 25575616, PMID 27082828

NIH funding

P30MH066386 (1)